MTBC’s Q3 revenue surpasses previous quarters combined — 7 takeaways

Medical Transcription Billing Corp. reported historic revenue growth in the third quarter of 2018, putting it on track for a record year. 

Advertisement

Here’s what you should know:

1. MTBC posted $17 million in third-quarter revenue, a year-over-year growth of 127 percent. The company’s third-quarter revenue exceeded its total revenue from the first half of the year, which was attributed to the company’s Orion acquisition in July.

2. MTBC generated $3.3 million of revenue from practice management services in the third quarter because of the acquisition. In the quarter, MTBC took over management services for three pediatric practices in Ohio and Illinois, as well as a group purchasing organization that generated $477,000 in revenue.

3. Cash flow from operations for the quarter was $2.8 million.

4. The company’s GAAP net loss of $1.6 million was an improvement of $3.8 million from the same period last year. Adjusted EBITDA also increased from the third quarter of 2017, reaching $3.4 million.

5. MTBC reported $34 million in revenue for the first nine months of 2018, an increase of 45 percent.

6. For the full year, MTBC is on track to grow its revenue by more than 50 percent year over year and increase its adjusted EBITDA by about 100 percent.

7. The company reaffirmed its full-year guidance. It projects revenue between $49 million and $50 million, and adjusted EBITDA between $4 million and $5 million.

More articles on coding, billing and collections:
GI societies praise CMS changes to ASC payment final rule
Newly opened Silver Cross Endoscopy Center finds spot in community — 5 insights
SSM Health building pediatric multispecialty facility, GI included — 3 insights

Advertisement

Next Up in ASC Coding, Billing & Collections

  • ASCs faced a mix of momentum and pressure throughout 2025. Procedure migration accelerated, technological innovation improved efficiency and new partnerships…

  • From high implant and supply costs to payer reimbursement pressures, ASCs are heading into 2026 with their margins squeezed from…

Advertisement

Comments are closed.